In the current work, we studied the tumor-persistence of the fluorescent anti-CEA nanobody over a prolonged time period in a patient-derived orthotopic xenograft (PDOX) mouse model of pancreatic cancer. The gene discussed is CEACAM5; the disease is neoplasm.